Squarepoint Ops LLC grew its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 33.2% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 161,146 shares of the company’s stock after purchasing an additional 40,157 shares during the quarter. Squarepoint Ops LLC owned approximately 1.55% of Direxion Daily S&P Biotech Bull 3x Shares worth $9,171,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Qube Research & Technologies Ltd purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter worth $26,000. Spire Wealth Management grew its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 46.3% in the 2nd quarter. Spire Wealth Management now owns 1,106 shares of the company’s stock worth $63,000 after acquiring an additional 350 shares during the last quarter. Headlands Technologies LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at about $69,000. SBI Securities Co. Ltd. raised its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 12.8% during the second quarter. SBI Securities Co. Ltd. now owns 3,388 shares of the company’s stock valued at $193,000 after acquiring an additional 385 shares during the last quarter. Finally, SG Americas Securities LLC raised its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 21.7% during the second quarter. SG Americas Securities LLC now owns 3,561 shares of the company’s stock valued at $203,000 after acquiring an additional 635 shares during the last quarter.
Direxion Daily S&P Biotech Bull 3x Shares Trading Up 0.2%
Direxion Daily S&P Biotech Bull 3x Shares stock opened at $164.81 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a 1-year low of $32.55 and a 1-year high of $176.44. The firm has a 50-day moving average of $133.47 and a 200-day moving average of $90.89.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Articles
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
- Best Energy Stocks – Energy Stocks to Buy Now
- Why Amazon Could Be a $300 Stock Within Weeks
- Should You Invest in Penny Stocks?
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
